- Home
- XCUR vs SER Comparison
XCUR vs SER Comparison
Compare XCUR & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- SER
- Stock Information
- Founded
- XCUR 2011
- SER 2017
- Country
- XCUR United States
- SER United States
- Employees
- XCUR N/A
- SER N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- XCUR Health Care
- SER Health Care
- Exchange
- XCUR Nasdaq
- SER Nasdaq
- Market Cap
- XCUR 43.6M
- SER 44.8M
- IPO Year
- XCUR N/A
- SER 2018
- Fundamental
- Price
- XCUR $10.15
- SER $4.61
- Analyst Decision
- XCUR
- SER
- Analyst Count
- XCUR 0
- SER 0
- Target Price
- XCUR N/A
- SER N/A
- AVG Volume (30 Days)
- XCUR 131.2K
- SER 18.7K
- Earning Date
- XCUR 11-14-2024
- SER 11-12-2024
- Dividend Yield
- XCUR N/A
- SER N/A
- EPS Growth
- XCUR N/A
- SER N/A
- EPS
- XCUR N/A
- SER N/A
- Revenue
- XCUR $500,000.00
- SER $3,157,500.00
- Revenue This Year
- XCUR N/A
- SER N/A
- Revenue Next Year
- XCUR N/A
- SER N/A
- P/E Ratio
- XCUR N/A
- SER N/A
- Revenue Growth
- XCUR N/A
- SER 2454.55
- 52 Week Low
- XCUR $1.44
- SER $3.81
- 52 Week High
- XCUR $36.00
- SER $23.18
- Technical
- Relative Strength Index (RSI)
- XCUR 43.92
- SER 44.15
- Support Level
- XCUR $10.20
- SER $4.60
- Resistance Level
- XCUR $11.40
- SER $5.00
- Average True Range (ATR)
- XCUR 1.38
- SER 0.29
- MACD
- XCUR 0.12
- SER 0.01
- Stochastic Oscillator
- XCUR 24.37
- SER 0.52
About XCUR Exicure Inc.
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.